HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
about
Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort.Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand
P2860
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@ast
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@en
type
label
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@ast
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@en
prefLabel
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@ast
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@en
P2093
P2860
P1476
HIV-1 Drug Resistance and Seco ...... Versus Higher RNA Thresholds.
@en
P2093
Abdel Babiker
Alexandra Compagnucci
Ann Melvin
Gareth Tudor-Williams
Linda Harrison
Lynda Harper
PENPACT-1 (PENTA 9PACTG 390) Study Team
Ross McKinney
Susan Fiscus
Yacine Saidi
P2860
P356
10.1097/QAI.0000000000000671
P407
P577
2015-09-01T00:00:00Z